Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.
Huang Y, Jiang H, Chen Y, Wang X, Yang Y, Tao J, Deng X, Liang G, Zhang H, Jiang W, Zhou R.
Huang Y, et al. Among authors: liang g.
EMBO Mol Med. 2018 Apr;10(4):e8689. doi: 10.15252/emmm.201708689.
EMBO Mol Med. 2018.
PMID: 29531021
Free PMC article.